Prior hypertension was the most prevalent risk factor in breast cancer, and the main medications used for prior hypertension included angiotensin receptor blockers (ARB), angiotensin-converting enzyme inhibitors (ACEI), thiazide diuretics and beta-blockers (BB). The gene discussed is ACE; the disease is breast carcinoma.